Ferric Carboxymaltose Injection [Injectafer®]

DRUG3 trials

Sponsors

Sichuan Huiyu Pharmaceutical Co., Ltd, AFT Pharmaceuticals, Ltd.

Conditions

Healthy AdultIron Deficiency Anemia (IDA)

Phase 1

Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants

CompletedNCT06895993

Sichuan Huiyu Pharmaceutical Co., LtdHealthy Adult

Start: 2025-04-07End: 2025-05-08Updated: 2025-05-18

Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions

RecruitingNCT07606105

Sichuan Huiyu Pharmaceutical Co., LtdHealthy Adult

Start: 2026-05-19End: 2027-01-26Target: 70Updated: 2026-05-26

Phase 3

A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia

Not yet recruitingNCT07687784

AFT Pharmaceuticals, Ltd.Iron Deficiency Anemia (IDA)

Start: 2026-12-01End: 2028-07-01Target: 1366Updated: 2026-07-08